Clinical Trial Update: Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating inhaled treprostinil to improve dyspnea and exercise tolerance in patients with mild chronic obstructive pulmonary diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Tyvaso (treprostinil)

Snippet

Sponsor: University of Alberta | Conditions: COPD (Chronic Obstructive Pulmonary Disease) | Phase 2 | Status: RECRUITING